Elon Musk shows support for weight loss drugs despite RFK Jr.'s criticism
Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
BioAge stock craters 70% on obesity drug study halt (update)
BioAge (BIOA) stock cratered 70% Friday evening after the company said it was discontinuing a Phase 2 study for its ...
BioSpace5d
Amgen to Add 370 New Jobs in North Carolina With $1B Manufacturing Investment
It is not clear what specifically the new facility will produce, though Amgen could be ramping up its manufacturing capacity ...
MarketBeat on MSN5d
Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair?
Amgen (NASDAQ: AMGN) recently released clinical results for its developmental weight loss drug MariTide. Shares fell by as ...
MM&M6d
Rx Rundown: Eli Lilly, Amgen, GSK and more
President-elect Donald Trump hosted the chief executives of Pfizer, Eli Lilly and PhRMA at Mar-a-Lago for a dinner with ...
GEN6d
Amgen Raises NC Investment to $1.5B with Plans for Second Plant
Amgen will raise its biomanufacturing investment in Holly Springs, NC, to $1.5 billion by establishing a second drug ...
Healthy Returns: Wall Street mulls over Amgen's weight loss drug data
Wall Street is chewing over data on Amgen’s weight loss injection, MariTde. Meanwhile, GE HealthCare will acquire a Japanese ...
Is Amgen Still a Top Dividend Stock?
Furthermore, the biotech's dividend program remains compelling despite near-term headwinds. Therefore, Amgen's combination of ...
Pharma giant planning $1B expansion in Holly Springs
Amgen (Nasdaq: AMGN) is investing more than $1 billion to expand its operations in Holly Springs, where the company already ...
Amgen to add 370 jobs as part of $1B investment in Holly Springs, NC officials say
Biopharma company Amgen plans to add 370 jobs as part of a new, $1.02 billion investment in Holly Springs. It’s the latest ...
STAT7d
‘Leptin’s last chance’: Mouse study says infamous weight loss drug failure could boost GLP-1s
Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...